Trial EudraCT 2020–001236–10
Publication Aman J, Lancet Respir Med, 2021
Primary outcome on the report: Time to discontinuation of ventilation and supplemental oxygen for more than 48 consecutive hours, while being alive during a 28-day period after randomisation.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.